|
| |
Image Results
Loading...
Loading...
ANGIOMAX Pages on BioPortfolio:
Biotechnology News ANGIOMAX Search
12 Oct 2009 ... Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/ANGIOMAX-news.htm...
|
BioPortfolio - Angiomax
For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over ...
http://www.bioportfolio.com/indepth/Angiomax.html...
|
Biotechnology News CLEVIPREX Search
Highlights for the second quarter of 2009: John Kelley, President and Chief Operating Officer, stated, 'The core business, Angiomax and Angiox, ...
http://www.bioportfolio.co.uk/CLEVIPREX-news.htm...
|
Results from other life science and pharmaceutical sites:
Angiomax
Angiomax® (bivalirudin) is a medicine that stops blood clotting (an anticoagulant). It helps prevent unwanted blood clotting during an "angioplasty.
"
http://www.csl.com.au/s1/cs/auhq/1217017237558/Web_Product_C...
|
Bivalirudin - Wikipedia, the free encyclopedia
In Europe Bivalirudin is sold under the brand name Angiox, and in other countries, including the United States, under Angiomax (the year of obtained
license ...
http://en.wikipedia.org/wiki/Bivalirudin...
|
Click-chemistry-conjugated oligo-angiomax in the two-dimensional ...
The recently arising antithrombin drug, angiomax, was successfully conjugated with a 5'-amino oligonucleotide through click chemistry. This oligo-angiomax ...
http://www.ncbi.nlm.nih.gov/pubmed/19275167...
|
Medicines Co. sues generic rivals over Angiomax - Yahoo! Finance
8 Oct 2009 ... PARSIPPANY, NJ (AP) -- The Medicines Co. said Thursday it filed three patent infringment lawsuits against drugmakers who are hoping to sell ...
http://biz.yahoo.com/ap/091008/us_medicines_co_patent_lawsui...
|
Angiomax Will Retain Decision Resources' Proprietary Clinical Gold ...
Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, ...
http://www.prnewswire.com/news-releases/angiomax-will-retain...
|
Bivalirudin (Angiomax) use during intracoronary brachytherapy may ...
We describe two cases of intracoronary vascular brachytherapy where bivalirudin (Angiomax), employed as an anticoagulant, led to abrupt vessel closure or ...
http://www.ncbi.nlm.nih.gov/pubmed/12652325...
|
REPLACE-2: Randomized Evaluation in PCI Linking Angiomax to ...
25 Nov 2003 ... Extended follow-up results demonstrate that the slightly increased incidence of non-Q-wave MI observed with bivalirudin at 30 days does not ...
http://www.medscape.com/viewarticle/461778...
|
DailyMed: About DailyMed
Angiomax® (bivalirudin) is a specific and reversible direct thrombin inhibitor. ... Angiomax is supplied in single-use vials as a white lyophilized cake, ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12006...
|
FDA Approvals: Angiomax, Lyrica, Zmax
16 Jun 2005 ... The FDA has approved an expanded indication for bivalirudin injection (Angiomax) , a new indication for pregabalin capsules (Lyrica), ...
http://www.medscape.com/viewarticle/506781...
|
www.nycomed.com - News release
The study compared the safety and efficacy between Angiomax and a combination of heparin plus GP IIb/IIIa inhibitor: Angiomax was superior to heparin alone ...
http://www.nycomed.com/en/Menu/Media/News+releases/Trial+con...
|
|
